文献速递流行病学与生物统计

一种非参数全局胜率方法用于不同量纲多终点和缺失数据的随机对照试验分析与样本量估算:超越O'Brien-Wei-Lachin方法

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien-Wei-Lachin.
PubMed 文献 · Stat Med · 2024-10-17

针对多终点量纲不同且存在缺失数据的随机对照试验,提出一种非参数全局胜率(gWinP)方法,将O'Brien-Wei-Lachin(OWL)方法作为特例纳入。该方法通过多元线性混合模型估计各终点胜率及协方差矩阵,并推导gWinP置信区间估计的样本量公式。模拟显示该方法在偏倚、区间覆盖率和达到预设精度方面表现良好。

要点

  • 提出非参数全局胜率gWinP量化多终点整体治疗效果,原假设为gWinP=0.50。
  • 该方法可处理缺失数据并校正基线测量,OWL方法为其特例。
  • 推导了基于gWinP置信区间估计的临床试验样本量公式。

核心结论

  • 提出的非参数全局胜率方法可处理多终点量纲不同和缺失数据,并校正基线测量,模拟显示在偏倚、区间覆盖率和达到预设精度方面表现良好。

研究设计与样本

  • 方法学研究,提出基于胜率的非参数分析方法并推导样本量公式,通过模拟评估方法性能,并提供SAS实现代码。

主要发现

  • 模拟结果显示该方法在偏倚、区间覆盖率和达到预设精度方面表现良好。

关键数值与推荐

  • 全局胜率gWinP为各终点胜率的平均值,原假设为gWinP=0.50。
  • 通过多元线性混合模型建模胜率分数,获得各终点胜率估计及协方差矩阵。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple primary endpoints are commonly used in randomized controlled trials to assess treatment effects. When the endpoints are measured on different scales, the O'Brien rank-sum test or the Wei-Lachin test for stochastic ordering may be used for hypothesis testing. However, the O'Brien-Wei-Lachin (OWL) approach is unable to handle missing data and adjust for baseline measurements. We present a nonparametric approach for data analysis that encompasses the OWL approach as a special case. Our approach is based on quantifying an endpoint-specific treatment effect using the probability that a participant in the treatment group has a better score than (or a win over) a participant in the control group. The average of the endpoint-specific win probabilities (WinPs), termed the global win probability (gWinP), is used to quantify the global treatment effect, with the null hypothesis gWinP = 0.50. Our approach involves converting the data for each endpoint to endpoint-specific win fractions, and modeling the win fractions using multivariate linear mixed models to obtain estimates of the endpoint-specific WinPs and the associated variance-covariance matrix. Focusing on confidence interval estimation for the gWinP, we derive sample size formulas for clinical trial design. Simulation results demonstrate that our approach performed well in terms of bias, interval coverage percentage, and assurance of achieving a pre-specified precision for the gWinP. Illustrative code for implementing the methods using SAS PROC RANK and PROC MIXED is provided.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Zou G, Zou L. A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien-Wei-Lachin. Stat Med. 2024. PMID: 39415652. doi:10.1002/sim.10247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。